{
    "SPADE_UN_11710": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_11710",
            "Peptide Name": "[K]3-VmCT1-NH2 VmCT1 petide derivative",
            "Source": "Synthetic construct",
            "Family": "Belongs to the scorpion NDBP 6 family",
            "Gene": "Not found",
            "Sequence": "FLKALWNVAKSVF",
            "Sequence Length": 13,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial"
            ],
            "Target Organism": "[Ref.27912176] Gram-negative bacteria:Escherichia coli (SBS 363)(MIC=1.56μmol/L);Pseudomonas aeruginosa (ATCC 27853)(MIC=0.78μmol/L);Escherichia coli (D31)(MIC=1.56μmol/L);Serratia marcescens (ATCC 4112)(MIC=1.56μmol/L);Enterobacter cloacae (beta-12)(MIC=6.25μmol/L);Gram-positive bacteria:Micrococcus luteus (A270)(MIC=0.78μmol/L);Staphylococcus aureus (ATCC 29213)(MIC=3.12μmol/L);Bacillus subtilis (ATCC 6633)(MIC=6.25μmol/L);Staphylococcus epidermidis (ATCC 12228)(MIC=3.12μmol/L);Fungi:Candida albicans MDM8(MIC=3.12μmol/L);Candida tropicalis (IOC 4560)(MIC=3.12μmol/L);Candida parapsilosis (IOC 4564)(MIC=6.25μmol/L);Aspergillus niger(MIC=12.5μmol/L);Cladosporium herbarum (ATCC 26362)(MIC=25μmol/L);Cryptococcus neoformans(MIC=3.12μmol/L)",
            "Hemolytic Activity": "[Ref.27912176] MHC=1.60 μmol/L against human red blood cells",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "The peptide adopts Helical fraction 0.10 in water;0.60 in TFE/Water;0.98 in POPC;0.52 in POPC:POPG;1 in POPC:DOPE;",
            "Formula": "C76H115N17O16",
            "Mass": 1522.83,
            "PI": 10.0,
            "Net Charge": 2,
            "Hydrophobicity": 0.94,
            "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min",
            "Function": "Antibacterial activity against the Gram-positive and Gram-negative bacteria and fungi.It presented higher or equivalent antimicrobial activity when compared to VmCT1.",
            "Literature": [
                {
                    "Title": "Novel designed VmCT1 analogs with increased antimicrobial activity.",
                    "Pubmed ID": "27912176",
                    "Reference": "Eur J Med Chem. 2017 Jan 27;126456-463.",
                    "Author": "Pedron CN, Torres MT, Lima JADS, Silva PI, Silva FD, Oliveira VX.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=27912176"
                },
                {
                    "Title": "novel designed VmCT1 analogs with increased antimicrobial activity",
                    "Pubmed ID": "",
                    "Author": "Pedron Cn, Torres MT, Lima JA, Silva PI, Silva FD, Oliveira VX"
                }
            ],
            "Frequent Amino Acids": "AFK",
            "Absent Amino Acids": "CDEGHIMOPQRTUY",
            "Basic Residues": 2,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 8,
            "Positive Residues": 2,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_12097",
                    "Similarity": 0.9230769230769231,
                    "Sequence": "FLKALWKVAKSVF"
                },
                {
                    "SPADE_ID": "SPADE_UN_12098",
                    "Similarity": 0.9230769230769231,
                    "Sequence": "FLKALWNVAKKVF"
                },
                {
                    "SPADE_ID": "SPADE_N_03252",
                    "Similarity": 0.9230769230769231,
                    "Sequence": "FLGALWNVAKSVF"
                }
            ]
        }
    }
}